News & Updates

A Brain Canada-funded platform is enabling new technology for drug discovery, in order to address a wide range of brain diseases and disorders: from epilepsy to autism, and brain tumors to ALS. 

A Canadian research team, based in Montreal and Halifax, is using sophisticated stem cell technology to uncover the causes of bipolar disorder, develop new ways to screen for it, determine who will respond to treatment, and begin to identify new drug therapies.

Canadian researchers are testing an innovative app-based therapy for postpartum depression and anxiety, and measuring whether improvements in a mother’s mental health result in changes to her child’s developing brain.

An AI-powered smart-phone app that enables doctors to monitor their patients’ symptoms, and their response to medication between appointments, shows promise as a new tool in the treatment of depression and anxiety, according to a recent research study.

Scientists at the Centre for Addiction and Mental Health (CAMH) in Toronto are set to test a novel approach to transcranial magnetic stimulation that may better organize the brain to relieve symptoms of depression, and possibly reduce the long-term risk of dementia.

A major clinical trial of accelerated theta-burst brain stimulation, funded by Brain Canada and Bell Let’s Talk, holds the promise of potentially easing the debilitating symptoms of treatment-resistant depression within a week.

Imagine a neurosurgeon using light or sound to manipulate specific cells in your brain and restore your brain health. Instead of implanting electrodes and buzzing broader areas of your brain to help relieve symptoms of Parkinson’s disease, for example, a neurosurgeon would use gene therapy to deliver light-sensitive proteins into specific brain cells affected by the disease and use light to stimulate only those cells.